The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development
Abstract
During melanoma development, transformed cells evade keratinocyte-mediated control by downregulating cell adhesion molecules. This study investigated the regulation of cell adhesion by hepatocyte growth factor (HGF) in melanoma. Melanocytes and two melanoma lines, WM164 and WM35, expressed normal level E-cadherin and Desmoglein 1, whereas most melanomas (18 out of 20) expressed no E-cadherin and significantly reduced Desmoglein 1. Overexpression of dominant negative E-cadherin and Desmoglein in melanocytes demonstrated that both molecules contribute to adhesion between melanocytes and keratinocytes. In contrast to melanocytes, most melanomas expressed HGF. All melanocytic cells expressed the HGF receptor c-Met, and autocrine HGF caused constitutive activation of c-Met, MAPK and PI3K. When autocrine activation was induced with HGF-expressing adenovirus, E-cadherin and Desmoglein 1 were decreased in melanocytes, WM164 and WM35. MAPK inhibitor PD98059 and PI3K inhibitor wortmannin partially blocked the downregulation, suggesting that both pathways are involved in this process. c-Met was coimmunoprecipitated with E-cadherin, Desmoglein 1 and Plakoglobin, suggesting that they form a complex (es) that acts to regulate intercellular adhesion. Together, the results indicate that autocrine HGF decouples melanomas from keratinocytes by downregulating E-cadherin and Desmoglein 1, therefore frees melanoma cells from the control by keratinocytes and allows dissemination of the tumor mass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the ability of melanoma cells to promote growth and invasion through the secretion of protumorigenic factors (11–13), it is plausible that beyond cancer cell–intrinsic mechanisms, phenotype plasticity and ferroptosis vulnerability of drug-resistant clones may involve autocrine or paracrine circuits.”
From Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis (2024) · cites this paper as [12]
Citations
Cites
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Woude, G. F. V., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,226
Molecular cloning and expression of human hepatocyte growth factor
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., & Shimizu, S. (1989) · Nature · doi:10.1038/342440a0 · Cited by 2,158
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,000
Morphogenetic roles of classic cadherins
Takeichi, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80102-2 · Cited by 1,467
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
Stoker, M. G. P., Gherardi, E., Perryman, M., & Gray, J. (1987) · Nature · doi:10.1038/327239a0 · Cited by 1,316
Drubin, D. G., & Nelson, W. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81278-7 · Cited by 1,030
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., Zonca, P. D., Giordano, S., Graziani, A., Panayotou, G., & Comoglio, P. M. (1994) · Cell · doi:10.1016/0092-8674(94)90318-2 · Cited by 994
Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers
Hirohashi, S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65575-7 · Cited by 839
Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., & Saito, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1320 · Cited by 788
Research works printed but not linked: 2
- Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA . 1991a Science 251: 802–804 · DOI
- Hsu MY, Wheelock MJ, Johnson KR, Herlyn M . 1996 J. Investig. Dermatol. Symp. Proc. 1: 188–194
Cited by
Sorted by citations
Items 101–200 of 211
Xie, L.-Q., Bian, L., Li, Z., Li, Y., Li, Z., & Ли, Б. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0922-6 · Cited by 32
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
Tanaka, R., Terai, M., Londin, E. R., & Sato, T. (2021) · Cancers · doi:10.3390/cancers13215457 · Cited by 32
Li, G., Fukunaga, M., & Herlyn, M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.012 · Cited by 32
Self-citationLee, A., Kim, J., Park, C., Lee, J. H., Lee, C.-H., & Do, B. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1174 · Cited by 31
Long-Lasting Molecular Changes in Human Skin after Repetitive In Situ UV Irradiation
Brenner, M., Coelho, S. G., Beer, J. Z., Miller, S. A., Wolber, R., Smuda, C., & Hearing, V. J. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.325 · Cited by 31
Nakamura, E., Sugihara, H., Bamba, M., & Hattori, T. (2005) · The Journal of Pathology · doi:10.1002/path.1718 · Cited by 31
Mer, A. H., Mirzaei, Y., Misamogooe, F., Bagheri, N., Bazyari, A., Keshtkaran, Z., Meyfour, A., Shahedi, A., Amirkhani, Z., Jafari, A., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01564-3 · Cited by 30
Fernández‐Barral, A., Orgaz, J. L., Baquero, P., Ali, Z., Moreno, A., Tiana, M., Gómez, V., Riveiro‐Falkenbach, E., Cañadas, C., Zazo, S., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.06.001 · Cited by 33
On the trail of the glycan codes stored in cancer-related cell adhesion proteins
Hoja-Łukowicz, D., Przybyło, M., Duda, M., Pocheć, E., & Bubka, M. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.08.007 · Cited by 30
The Role of MET in Melanoma and Melanocytic Lesions
Zhou, Y., Song, K. Y., & Giubellino, A. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.08.002 · Cited by 30
Fernández‐Barral, A., Orgaz, J. L., Gómez, V., del Peso, L., Calzada, M. J., & Jiménez, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032989 · Cited by 30
Furukawa, K., Kambe, M., Miyata, M., Ohkawa, Y., Tajima, O., & Furukawa, K. (2013) · Cancer Science · doi:10.1111/cas.12310 · Cited by 29
Tumor cell plasticity: the challenge to catch a moving target
Schwitalla, S. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0943-1 · Cited by 28
Rickelt, S., Franke, W. W., Dörflinger, Y., Goerdt, S., Brandner, J. M., & Peitsch, W. K. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0704-7 · Cited by 28
The role of intracellular protein O-glycosylation in cell adhesion and disease
Bektas, M., & Rubenstein, D. S. (2011) · Journal of Biomedical Research · doi:10.1016/s1674-8301(11)60031-6 · Cited by 26
The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment
Marrapodi, R., & Bellei, B. (2024) · Cancers · doi:10.3390/cancers16050913 · Cited by 28
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis
More, S., Bonnereau, J., Wouters, D., Spotbeen, X., Karras, P., Rizzollo, F., Killian, T., Venken, T., Naulaerts, S., Vervoort, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6164 · Cited by 25
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
Neuendorf, H. M., Simmons, J. L., & Boyle, G. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1183328 · Cited by 26
Anatomy and Physiology of the Skin
Dehdashtian, A., Stringer, T. P., Warren, A., Mu, E. W., Amirlak, B., & Shahabi, L. (2018) · Springer eBooks · doi:10.1007/978-3-319-78310-9_2 · Cited by 26
Shinomiya, N., & Woude, G. F. V. (2003) · PubMed · Cited by 22
Recent discoveries in the genetics of melanoma and their therapeutic implications
Marquette, A., Bagot, M., Bensussan, A., & Dumaz, N. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0043-5 · Cited by 22
Ayoub, N. M., Akl, M. R., & Sylvester, P. W. (2013) · Cell Proliferation · doi:10.1111/cpr.12059 · Cited by 21
Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
Liu, S., Li, S., Wang, B., Liu, W., Gagea, M., Chen, H., Sohn, J., Parinyanitikul, N., Primeau, T. M., Do, K.-A., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0710 · Cited by 20
Discohesive malignant melanoma simulating a bullous dermatoses
Kartono, F., Shitabata, P. K., MAGRO, C. M. J., & Rayhan, D. J. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.01054.x · Cited by 20
Growth Factors and Oncogenes as Targets in Melanoma: Lost in Translation?
Kwong, L. N., Chin, L., & Wagner, S. N. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.07.015 · Cited by 19
Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin
Lee, J., Kim, K. E., Cheon, S., Song, J. H., Houh, Y., Kim, T. S., Gil, M., Lee, K. J., Kim, S., Kim, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11669 · Cited by 19
Contribution of Keratinocytes in Skin Cancer Initiation and Progression
Dainese--Marque, O., Garcia, V., Andrieu‐Abadie, N., & Riond, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168813 · Cited by 19
Hügel, R., Muendlein, A., Volbeding, L., Drexel, H., Richtig, E., Wehkamp, U., Painsi, C., Lange‐Asschenfeldt, B., Hauschild, A., & Egberts, F. (2016) · Melanoma Research · doi:10.1097/cmr.0000000000000269 · Cited by 18
Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma
Han, Y., Li, X., Yan, J., Ma, C., Wang, X., Pan, H., Zheng, X., Zhang, Z., Gao, B., & Ji, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581985 · Cited by 18
Therapeutic Targeting of the Receptor Tyrosine Kinase Met
Sattler, M., Ma, P. C., & Salgia, R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_7 · Cited by 18
Zhao, Y., Zhao, J., Mialki, R. K., Wei, J., Spannhake, E. W., Salgia, R., & Natarajan, V. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00417.2012 · Cited by 17
Denhardt, D. T. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23708.x · Cited by 16
Molecular targets in melanoma: Strategies and challenges for diagnosis and therapy
Herlyn, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21605 · Cited by 16
Self-citationAdvances in malignant melanoma: genetic insights from mouse and man
Kabbarah, O. (2006) · Frontiers in bioscience · doi:10.2741/1849 · Cited by 14
Elsen, S., Lerut, E., Cleynenbreugel, B. V., der Aa, F. V., van Poppel, H., & de Witte, P. A. M. (2015) · British Journal of Urology · doi:10.1111/bju.13113 · Cited by 13
Molecular targets for tivantinib (ARQ 197) and vasculogenic mimicry in human melanoma cells
Kumar, S. R., Gajagowni, S., Bryan, J. N., & Bodenhausen, H. M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.010 · Cited by 13
Katagata, Y., Aoki, T., Kondo, S., Kawa, Y., & Mizoguchi, M. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640193 · Cited by 14
The HGF-cMET signaling pathway in conferring stromal-induced BRAF-inhibitor resistance in melanoma
Filitis, D. C., Rauh, J., & Mahalingam, M. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000194 · Cited by 11
Sokhi, U. K., Bacolod, M., Dasgupta, S., Emdad, L., Das, S. K., Dumur, C., Miles, M., Sarkar, D., & Fisher, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076284 · Cited by 17
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
Fontana, F., Sommariva, M., Anselmi, M., Bianchi, F., Limonta, P., & Gagliano, N. (2024) · Cells · doi:10.3390/cells13020181 · Cited by 11
Paye, J. M. D., Akers, R. M., Huckle, W. R., & Forsten‐Williams, K. (2007) · Cell Communication & Adhesion · doi:10.1080/15419060701463116 · Cited by 11
Molecular Biology of Malignant Melanoma
Pons, M., Mancheño‐Corvo, P., Martín‐Duque, P., & Quintanilla, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77574-6_20 · Cited by 11
Journal of Cutaneous Pathology
Wilentz, D., Vyas, N. S., Johnston, K., & Rubenstein, R. M. (2010) · Journal of Cutaneous Pathology · doi:10.1111/(issn)1600-0560 · Cited by 11
NRF2 in the Epidermal Pigmentary System
Ogawa, T., & Ishitsuka, Y. (2022) · Biomolecules · doi:10.3390/biom13010020 · Cited by 9
Kalabis, J., Li, G., Fukunaga‐Kalabis, M., Rustgi, A. K., & Herlyn, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90294.2008 · Cited by 9
Self-citationEffect of long-wave UV radiation on mouse melanoma: an in vitro and in vivo study
Pastila, R. K. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 9
The HGF/MET Signaling and Therapeutics in Cancer
Thewke, D. P., Kou, J., Fulmer, M. L., & Xie, Q. R. (2017) · Current human cell research and applications · doi:10.1007/978-981-10-7296-3_8 · Cited by 8
Amschler, K., Beyazpinar, I., Erpenbeck, L., Kruss, S., Spatz, J. P., & Schön, M. P. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.09.027 · Cited by 8
Molecular Events in Skin Cancer
Meyer, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-78574-5_16 · Cited by 8
Marrapodi, R., Kovacs, D., Migliano, E., Caputo, S., Papaccio, F., Pallara, T., Cota, C., & Bellei, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167901 · Cited by 7
Aktary, Z., McMahon, M., & Larue, L. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_32-1 · Cited by 9
Bae, S. H., Oh, S., Yoon, S. K., Park, J. A., Kim, G. D., Hur, W., Choi, J. Y., Oh, I., & Yoon, K. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.3.367 · Cited by 7
BRN2 in Melanocytic Cell Development, Differentiation, and Transformation
Cook, A. L., Boyle, G. M., Leonard, J. H., Parsons, P. G., & Sturm, R. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_8 · Cited by 7
Emerging concepts and technologies in melanoma research
Herlyn, M. (2002) · Melanoma Research · doi:10.1097/00008390-200202000-00002 · Cited by 7
Self-citationKhandelwal, A. R., Echanique, K. A., John, M. S., & Nathan, C. (2021) · Otolaryngologic clinics of North America · doi:10.1016/j.otc.2020.11.002 · Cited by 5
Pleshkan, V. V., Zinovyeva, M. V., & Sverdlov, E. D. (2011) · Molecular Biology · doi:10.1134/s0026893311030149 · Cited by 5
Melanocyte signaling pathways and the etiology of melanoma
Wagner, A. J., & Fisher, D. E. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.017 · Cited by 5
The Dynamic Roles of Cell-Surface Receptors in Melanoma Development
Fang, D., & Herlyn, M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_9 · Cited by 5
Self-citationProspects for non-immunological molecular therapeutics in melanoma.
Eustace, A. J., Mahgoub, T., Tryfonopoulos, D. J., O’Donovan, N., & Crown, J. P. (2010) · PubMed · Cited by 4
Early diagnosis of melanoma: what do we know?
Yee, E., Hoffman, R. M., & Berwick, M. (2007) · Cited by 4
The Role of Endothelin 3 in Melanoma Progression and Metastasis
Chin, N. L. (2015) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc000185 · Cited by 3
Gene targeting in melanoma therapy: exploiting of surface markers and specific promoters
Алексеенко, И. В., Zinovyeva, M. V., Pleshkan, V. V., & Sverdlov, E. D. (2012) · Biopolymers and Cell · doi:10.7124/bc.000027 · Cited by 3
Inflammation and Lung Cancer: The Role of Epithelial–Mesenchymal Transition
Walser, T. C., Park, S. J., Yanagawa, J., & Dubinett, S. M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2724-1_2 · Cited by 4
Mione, M., Liebig, J. K., Muñoz, L., & Bosserhoff, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_6 · Cited by 3
Schowalter, M. K., Dulmage, B., Ho, J., Vu, J. R., Falo, L. D., & Geskin, L. J. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000070 · Cited by 2
Heuristic Modelling Applied to Epidermal Homeostasis
Iris, F., Géa, M., Lampe, P.-H., & Querleux, B. (2014) · Pan Stanford Publishing eBooks · doi:10.1201/b17205-21 · Cited by 2
Melanoma Development and Pigment Cell Transformation
Wellbrock, C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_14 · Cited by 2
The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy
Anderson, M., & Jankowski, J. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.577 · Cited by 2
Molecular spectrum of pigmented skin lesions: from nevus to melanoma
Jiang, H. L., Wortsman, J., Matsuoka, L. Y., Granese, J., Carlson, J. A., Mihm, M. C., & Slominski, A. T. (2006) · Expert Review of Dermatology · doi:10.1586/17469872.1.5.679 · Cited by 2
The Tumor Microenvironment in Cutaneous Melanoma: Friend or Foe
Straume, O., & Schuster, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_21 · Cited by 1
Aktary, Z., McMahon, M., & Larue, L. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_32 · Cited by 1
Mueller, D. W., & Bosserhoff, A. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_6 · Cited by 1
Moira, R. J., & Stephen, P. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_77 · Cited by 1
Epigenetics: A Possible Link Between Stress and Melanocyte Malignant Transformation
Molognoni, F., & Jasiulionis, M. G. (2011) · InTech eBooks · doi:10.5772/20637 · Cited by 1
Anoikis Resistance in Melanoma
Simmons, J. L., Ng, M. F., Neuendorf, H. M., & Boyle, G. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-73856-3_7 · Cited by 1
Tumor Microenvironment for Melanoma Cells
Wu, L. W., Herlyn, M., & Zhang, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_14 · Cited by 1
Self-citationThe Transformed Phenotype of Melanocytes
Fang, D., & Herlyn, M. (2006) · doi:10.1002/9780470987100.ch25 · Cited by 1
Self-citationNovel mechanisms of Stat3 activation
Arulanandam, R. (2010) · QSpace (Queen's University Library) · Cited by 1
Villanueva, J., & Herlyn, M. (2009) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0001894.pub2 · Cited by 1
Self-citationDynamics of Cell Adhesion Interactions during Melanoma Development
Li, G., & Herlyn, M. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_5
Self-citationTumor Microenvironment for Melanoma Cells
Zhang, G., & Herlyn, M. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_14
Self-citationDynamics of cell-cell junctions in keratinocytes
Chavez, M. G. (2009) · UNM’s Digital Repository (University of New Mexico)
The Biology and Genetics of Melanoma
Sharpless, N. E., & Chin, L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_15
Targeting BRAF/MEK in melanoma: new hope or another false dawn?
Smalley, K. S. M., Herlyn, M., & Flaherty, K. T. (2007) · Expert Review of Dermatology · doi:10.1586/17469872.2.2.179
Self-citationMelissa, J. A., & Paye, D. (2003)
Radiation, U. (2006)
Biologie des Melanoms: Signaltransduktionsmolekule als Zielstrukturen für die Melanomtherapie
Schittek, B., Sinnberg, T. W., & Meier, F. E. (2006) · Springer eBooks · doi:10.1007/3-540-28988-7_2
López‐Fauqued, M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Einfluss ultravioletter Strahlung auf maligne Melanomzellen in Hautrekonstrukten
München, L.-M.-U., & Ruzicka, T. (2008)
Mutasim, D. F., Kadekaro, A. L., Pipitone, M. A., & ABDEL‐MALEK, Z. A. (2005) · CRC Press eBooks · doi:10.1201/9780203503430.ch18
Local IL-15-immunotherapy to treat melanoma
Hanes, M. R. (2017) · DalSpace (Dalhousie University)
A Comprehensive Data Analysis of Differentially Regulated Genes in MelanomaPreprint
Han, Y., Li, X., Yan, J., Ma, C., Wang, X., Pan, H., Zheng, X., Zhang, Z., Gao, B., & Ji, X. (2020) · doi:10.21203/rs.3.rs-19035/v1
Yaar, M. (2006) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8254.465743
Yang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J. H., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023) · doi:10.1158/0008-5472.c.6499020.v1
Self-citationYang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J. H., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023) · doi:10.1158/0008-5472.22378812.v1
Self-citationYang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J. H., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023) · doi:10.1158/0008-5472.c.6499020
Self-citationYang, J., Price, M. A., Li, G. Y., Bar‐Eli, M., Salgia, R., Jagedeeswaran, R., Carlson, J. H., Ferrone, S., Turley, E. A., & McCarthy, J. B. (2023) · doi:10.1158/0008-5472.22378812
Self-citationPinnix, C. C., Lee, J. T., Liu, Z., McDaid, R., Balint, K., Beverly, L. J., Brafford, P. A., Xiao, M., Himes, B. T., Zabierowski, S. E., et al. (2023) · doi:10.1158/0008-5472.22377707
Self-citation
Metadata
- Authors
- Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K., & Herlyn, M.
- Affiliations
- The Wistar Institute (US)
- Ehime University (JP)
- Corresponding author
- Herlyn, Meenhard
- Venue
- Oncogene
- Published
- 2001-12-06
- Volume
- 20
- Issue
- 56
- Pages
- 8125-8135
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2010980929
- Cited by
- 212
- References
- 94
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 8 · 2013: 9 · 2012: 9
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Tokyo
- National Institutes of Health
- National Cancer Institute (R01CA047159, CA 47159, R01CA080999, CA-10815, CA 76674, CA-25874, R01CA076674, CA80999, P01CA025874, P30CA010815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- melanoma, hepatocyte growth factor, E-cadherin, desmoglein 1, c-Met, autocrine signaling, cell adhesion, plakoglobin, MAPK signaling, PI3K signaling, metastasis, melanocytes
- MeSH terms
- Cell Adhesion, Cytoskeletal Proteins, Humans, Melanocytes, Melanoma, Precipitin Tests, RNA, Neoplasm, Tumor Cells, Cultured, Signal Transduction, Down-Regulation, Keratinocytes, Cadherins, Hepatocyte Growth Factor, Proto-Oncogene Proteins c-met, Phosphatidylinositol 3-Kinases, Autocrine Communication, Mitogen-Activated Protein Kinases, Desmoplakins, Desmogleins, Desmoglein 1, gamma Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review